STAT6 and breast carcinoma: Next, we determined whether DVL2 binds to the promoter regions of genes involved in antigen presentation (HLA-A, HLA-C) and T-cell maintenance (STAT1, STAT6, TGFB1) in HER2-positive breast cancer cells.